Skip to main content
. 2017 Oct 24;9(10):140. doi: 10.3390/cancers9100140

Figure 4.

Figure 4

Structures of commonly used PDK1 inhibitors. (A) 2-O-Bn-InsP5 (M. Falasca Laboratory); (B) OXIDs (S. Rapposelli Laboratory); (C) GSK2334470 (GlaxoSmithKline); (D) MP7 (Merck).